undamentalytics Newsletter

Riedel Norbert G: insider trades

Officer, Director at 2 companies we cover. No open-market purchases and 15 sales not made under a pre-set plan, reported from March 9, 2010 to March 2, 2026.

What happened after Riedel Norbert G’s sales?

After their sales, the shares moved −14.8% against the index over 12 months on average (a negative figure means selling was the right call); 71% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Riedel Norbert G: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 15 −6.5% −12.0% 67% 13 −1.58 0.14 No reliable evidence
Sales, 12 months after the report 14 −14.8% −18.1% 71% 12 −2.64 0.023 Some evidence: seller right
Sales, 12 months after the trade 14 −14.2% −16.6% 71% 12 −2.74 0.019 Some evidence: seller right

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Jazz Pharmaceuticals plc JAZZ —013May 29, 2014March 2, 2026
Baxter International BAX Corporate Vice President02March 9, 2010August 6, 2012

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
March 2, 2026February 27, 2026 JAZZ Sale $655,680 +9.2%not yetnot yet
August 15, 2023August 14, 2023 JAZZ Sale $171,457 −12.0%−47.5%−45.0%
August 9, 2022August 5, 2022 JAZZ Sale $1,412,836 −0.7%−19.3%−24.3%
August 10, 2021August 6, 2021 JAZZ Sale $193,236 −14.6%+10.4%+8.1%
August 10, 2020August 7, 2020 JAZZ Sale $117,185 +12.2%−17.1%−14.4%
August 12, 2019August 9, 2019 JAZZ Sale $98,482 −10.2%−29.8%−25.4%
August 13, 2018August 10, 2018 JAZZ Sale $116,563 −12.2%−27.7%−27.7%
August 14, 2017August 11, 2017 JAZZ Sale $94,248 −12.2%+2.2%+5.2%
August 17, 2016August 15, 2016 JAZZ Sale $86,373 −18.2%−7.2%−8.5%
May 17, 2016May 16, 2016 JAZZ Sale $93,509 −16.7%−19.0%−16.9%
August 11, 2015August 10, 2015 JAZZ Sale $144,178 −26.2%−31.7%−23.2%
May 14, 2015May 12, 2015 JAZZ Sale $113,010 +4.6%−15.7%−16.2%
May 29, 2014May 28, 2014 JAZZ Sale $91,764 +10.3%+14.6%+13.7%
August 6, 2012August 3, 2012 BAX Sale $4,136,674 +11.6%+5.0%+0.9%
March 9, 2010March 5, 2010 BAX Sale $4,482,324 −22.9%−24.3%−25.5%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Riedel Norbert G traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.